Inhibition of norepinephrine reuptake and size of myocardial infarction during focal ischemia and after preconditioning

Bulletin of Experimental Biology and Medicine

Volumn 150, Issue 1, 2010, Pages 15-17

  Naumenko, S E ^a   Latysheva, T V ^b   Gilinskii, M A ^b  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^b NONE

Author keywords

Desipramine; Ischemic preconditioning; Myocardial ischemia; Norepinephrine

Indexed keywords

DESIPRAMINE; NORADRENALIN;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; DRUG MECHANISM; EXOCYTOSIS; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; INHIBITION KINETICS; INJURY SEVERITY; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; NORADRENALIN UPTAKE; RAT;

ANIMALS; DESIPRAMINE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NOREPINEPHRINE; RANDOM ALLOCATION; RATS; RATS, WISTAR;

RATTUS;

EID: 79951623864     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-010-1056-3     Document Type: Article

References (7)

1. S. E. Naumenko, T. V. Latysheva, and M. A. Gilinskii, Ross. Fiziol. Zh., 94, No. 5, 532-538 (2008).
2. H. W. Cohen, G. Gibson, and M. H. Alderman, Am. J. Med., 108, No. 1, 2-8 (2000).
3. T. Miura, S. Kawamura, H. Tatsuno, et al., Circulation, 104, No. 9, 1053-1058 (2001).
4. D. Richardt, A. Dendorfer, R. Tolg, et al., Can. J. Physiol. Pharmacol., 84, No. 11, 1185-1189 (2006).
5. A. F. Rump, J. Schierholz, and W. Klaus, Arzneimittelforschung, 52, No. 7, 543-551 (2002).
6. A. Schömig, Circulation, 82, No. 1, Suppl. II, 13-22 (1990).
7. M. Seyfarth, G. Richardt, A. Mizsnyak, et al., Circ. Res., 78, No. 4, 573-580 (1996).